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Introduction
Functional electrical stimulation (FES) cycling is 
commonly prescribed for people with spinal cord injury for 
a variety of reasons (Carlson et al 2009, Hicks et al 2011). 
Some of the proposed beneﬁts of FES cycling include 
increased urine output, decreased lower limb swelling 
and decreased spasticity (Elokda et al 2000, Faghri and 
Yount 2002, Krause et al 2008, Sampson et al 2000, Skold 
et al 2002, van der Salm et al 2006). It is important to 
investigate the therapeutic effects of FES cycling on these 
variables because: increased urine output is associated with 
a reduced incidence of urinary tract infection (Wilde and 
Carrigan 2003); decreased lower limb swelling makes it 
easier for people with spinal cord injury to lift their legs 
and reduces incidence of pressure ulcers (Consortium for 
Spinal Cord Medicine Clinical Practice Guidelines 2001); 
and decreased spasticity has various functional and health 
beneﬁts (Adams and Hicks 2005).
Anecdotal evidence suggests that FES cycling affects 
renal function causing an increase in urine output and 
decrease in lower limb swelling (Man et al 2003). It is 
hypothesised that the cyclic muscle contractions associated 
with FES cycling compress the lower limb vasculature 
thereby improving venous return and decreasing lower 
limb swelling (Elokda et al 2000, Faghri and Yount 2002, 
Man et al 2003, Sampson et al 2000). It is also claimed that 
the increased venous return associated with FES cycling 
stretches the myocardium of the right atrium stimulating 
the expression of atrial natriuretic peptide. This peptide is 
known to have an excitatory effect on the kidneys, which 
increases urine excretion (Dunn and Donnelly 2007) and 
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What is already known on this topic: Functional 
electrical stimulation of paralysed legs in people with 
spinal cord injury increases venous return which 
may increase urine output and decrease lower limb 
swelling. Functional electrical stimulation may also 
have short-term effects on spasticity.
What this study adds: This study provides unbiased 
point estimates of the effect of functional electrical 
stimulation on urine output, venous return and 
spasticity. These estimates indicate that our current 
conﬁdence in the effectiveness of functional electrical 
stimulation on these outcomes is not yet justiﬁed.
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potentially decreases lower limb swelling. However, it is not 
known whether FES cycling is a sufﬁciently potent stimulus 
to inﬂuence urine output or lower limb swelling. This has 
not been tested in a randomised controlled trial.
FES cycling is also advocated as a way to reduce spasticity 
(Elbasiouny et al 2010, Krause et al 2008, Skold et al 
2002, van der Salm et al 2006). Various theories exist on 
how this may occur. One theory is that repeated electrical 
stimulation (ES)-evoked contractions lead to muscle fatigue 
(Skold et al 2002). Another hypothesis is that the excitation 
of the cutaneous afferents decreases the excitability of the 
propriospinal interneurons and motoneurons (Elbasiouny et 
al 2010), while others argue that ES applied to antagonistic 
muscles augments reciprocal inhibition of agonistic spastic 
muscles (van der Salm et al 2006). However, similar to 
the beliefs about FES cycling on urine output and lower 
limb swelling, it is not yet clear whether FES cycling 
affects spasticity. There are some studies indicating an 
immediate dampening of spasticity from one-off episodes 
of ES but these studies are vulnerable to bias and do not 
provide convincing evidence of the effects of FES cycling 
on spasticity (Krause et al 2008, Skold et al 2002, van der 
Salm et al 2006). Therefore, the research question for this 
study was:
Does a two-week FES cycling program increase urine 
output and decrease lower limb swelling and spasticity 
in people with recent spinal cord injury?
Method
Design
A 5-week cross-over randomised trial was undertaken, where 
participants received both experimental and control phases. 
Each participant underwent the 2-week control phase and 
the 2-week experimental phase. During the experimental 
phase, participants received FES cycling for 2 weeks. 
During the control phase, participants did not receive any 
FES cycling. The order of the two phases was randomised 
with a 1-week washout period in between. Participants 
continued to receive other usual care throughout the trial.
A blocked randomisation allocation schedule was 
computer-generated by an independent person to ensure 
equal numbers of participants commenced with the FES 
cycling phase and control phase (Schulz et al 2010). Each 
participant’s allocation was placed in a sealed, opaque and 
sequentially numbered envelope and kept at an off-site 
location. Once a participant passed the initial screening 
process, an independent person was contacted, an envelope 
opened and allocation revealed. The participant was deemed 
to have entered the trial at this point.
Participants
Fourteen participants with an upper motor neuron lesion 
following recent spinal cord injury were consecutively 
recruited from two Sydney spinal cord injury units over an 
18-month period commencing July 2011. Participants were 
included if they: had sustained a spinal cord injury (traumatic 
or non-traumatic) within the preceding six months; were 
currently receiving inpatient rehabilitation; were over 16 
years of age; were diagnosed with an American Spinal 
Cord Injury Association Impairment Scale (AIS) of A, B 
or C with less than 5/50 lower limb strength according to 
the International Standards for Neurological Classiﬁcation 
of Spinal Cord Injury; and could tolerate FES cycling for 
at least 20 minutes within a one-hour period. Participants 
were excluded if: they had participated in a FES cycling 
program in the preceding two weeks; ES was medically 
contraindicated; or they had a limited ability to comply. 
All participants were deemed medically ﬁt to participate by 
their treating medical consultant.
Intervention
Participants in the experimental phase received a progressive, 
individualised FES cycling program performed four times 
a week for two weeks. The aim was to provide participants 
with 30 to 45 minutes of FES driven leg cycling within a 
one-hour session with the option of participants building 
up to this time from 20 minutes. However, all participants 
tolerated at least 30 minutes from the start. Three muscle 
groups were stimulated for each leg; quadriceps, hamstrings, 
and gluteals. Electrodes were placed over two points on each 
muscle to provide a maximal contraction. One participant 
did not tolerate stimulation of the quadriceps; therefore the 
gastrocnemius was stimulated instead. FES cycling was 
performed using a leg FES cycling systema, with participants 
seated in their wheelchairs. A FES protocol based on that 
recommended by others (Krause et al 2008) was used with 
the following parameters: frequency 33Hz, wavelength 
350h and stimulation amplitude of up to 140mA according 
to participants’ tolerance to ES. Resistance was set at the 
highest level that still enabled participants to cycle for at 
least 30 minutes. The initial sessions for each participant 
were supervised on a one-to-one basis by a physiotherapist 
with at least four years of experience in the management 
of spinal cord injury. Later sessions for participants were 
sometimes supervised by a physiotherapist aide working 
under the guidance of a physiotherapist.
The usual care that was provided during both intervention 
phases of the study consisted of standard inpatient 
physiotherapy and occupational therapy that is typically 
provided to patients during their initial rehabilitation 
following spinal cord injury. This includes interventions 
directed at impairments such as poor strength, restricted 
joint mobility, limited ﬁtness, reduced dexterity, and pain. It 
also includes a strong focus on training of functional skills 
such as dressing, walking, transferring, using the hands, 
and pushing a wheelchair.
Outcome measures
All assessments were conducted at the beginning (baseline) 
and end of each two-week phase by trained assessors who 
were blinded to group allocation. The success of blinding 
was determined by asking assessors at the completion of 
each participant’s last assessment whether they had been 
unblinded.
The primary outcome was urine output. Secondary 
outcomes were lower limb swelling measured as lower leg 
circumference, and spasticity measured using the Ashworth 
Scale and the Patient Reported Impact of Spasticity 
Measure (PRISM). An additional secondary outcome 
measure, Global Impression of Change, was collected at the 
completion of the trial.
Baseline urine output was measured prior to the 
commencement of each trial phase with the participant 
sitting quietly and avoiding any activity. Urine output was 
again measured at the end of both experimental and control 
phases, however at the end of experimental phase urine 
output was measured while participants simultaneously 
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performed FES cycling. Urine output was measured each 
time over a one-hour period. Prior to all one-hour collection 
periods, participants’ bladders were emptied via a catheter. 
If intermittent self-catheterisations were used for bladder 
management, an indwelling catheter was temporarily 
inserted to ensure consistency between measurements. In 
addition, ﬂuid intake was restricted for three hours prior 
to the collection period according to normal recommended 
daily intake for weight (Spinal Cord Medicine Consortium 
1998). Where possible, participants’ bladder management 
remained constant throughout the trial although two 
participants changed bladder management from indwelling 
catheters – one to a suprapubic catheter and the other to 
intermittent self-catherisations – for reasons unrelated to 
the trial.
Spasticity was measured before and after the experimental 
and control phases of the trial using the Ashworth Scale 
(Cardenas et al 2007). Measurements were performed in the 
supine position for quadriceps, hamstrings, plantarﬂexor, 
and hip adductor muscles (0–4). Scores for each muscle 
group of the left and right legs were tallied and treated 
as one overall measure of lower limb spasticity (0–32) as 
recommended by others (Hobbelen et al 2012).
Lower limb swelling was measured before and after the two 
phases of the trial using the ‘Leg-o-meter’, a reliable and valid 
tool that uses a tape measure to quantify leg circumference 
(Berard and Zuccarelli 2000). Circumferential measures 
were taken 13 cm from the base of the heel, directly 
posterior to the medial malleoli.
Participants were asked to complete the Patient Reported 
Impact of Spasticity Measure (PRISM) questionnaire 
before and after the control and experimental phases. 
The questionnaire explores participants’ experiences of 
abnormal muscle control or involuntary muscle movement 
over the preceding week. It asks participants to rate their 
abnormal muscle control or involuntary movement for 41 
scenarios on a 5-point scale ranging from 0 (‘never true for 
me’) to 4 (‘very often true for me’) with a maximal possible 
score of 164 reﬂecting severe spasticity. Its reliability has 
been established (Cook et al 2007). 
At the end of the trial, participants were asked to rate their 
perceptions about the overall effects of FES cycling using 
a 15-point Global Impression of Change Scale anchored 
at –7 by ‘markedly worse’ and at +7 by ‘markedly better’ 
(Schneider et al 1997). In addition, they were also asked to 
rate the inconvenience of the FES cycling phase of the trial 
on a 10-cm Visual Analogue Scale anchored at one end with 
0 reﬂecting ‘not at all inconvenient’ and at the other end with 
10 reﬂecting ‘extremely inconvenient’. Participants were 
also asked open-ended questions to explore any perceived 
deleterious or beneﬁcial effects of the FES cycling.
Data analysis
Change data (pre to post difference) for each phase were 
used to derive point estimates of the differences between 
the experimental and control phases. The analysis did 
not address the possibility of an order or phase effect as 
any potential for an order effect was accounted for by the 
blocked randomisation schedule and any potential for a 
phase effect was minimised by the 1-week washout period. 
This approach is recommended by others (Senn 2002).
Power calculations were not conducted because there 
were no previous studies upon which to base a sensible 
estimate of the likely SD for urine output or with which 
to set a minimally worthwhile treatment effect. Therefore, 
a pragmatic approach to determining the sample size 
was adopted. That is, we selected a sample size that was 
realistically achievable within a 2-year recruitment period 
even though ultimately we recruited within a 1.5-year 
period. We reasoned that an estimate of treatment effect 
even if imprecise from a trial with minimal bias would 
progress knowledge in this area and help sample size 
calculations for future trialists.
Results
Flow of participants through the study
Fourteen participants entered and completed the study. 
Their median (interquartile range) age was 25 years (22 
to 32) and time since injury was 118 days (64 to 135). All 
participants had motor complete lesions (AIS A, B) with 
neurological levels ranging from C4 to T10, as presented 
in Table 1. Figure 1 demonstrates the ﬂow of participants 
through the trial.
Compliance with the trial method
Primary and secondary outcomes were attained for every 
participant with no drop outs. The assessors remained blind 
for all aspects of the trial. Participants received a median 
of 8 FES cycling sessions (IQR 8 to 9) over a mean of 2 
weeks (SD 0.5). There was some variation because the FES 
cycling was continued until the assessment at the end of 
the 2-week FES cycling phase could be completed. These 
assessments were sometimes delayed for a day or more 
because of difﬁculties with scheduling.
5BCMF. Baseline characteristics of participants.
Characteristics Randomised 
(n = 14)
Age (yr), median (IQR) 25 (22 to 32)
Time since injury (d), median 
(IQR)
118 (64 to 135)
Gender, n (%) male 11 (79)
AIS, n
 A 13
 B 1
 C 0
Neurological level, n
 C4 3
 C5 2
 C6 1
 C7 2
 T3 1
 T4 2
 T6 1
 T8 1
 T10 1
Bladder management, n
 IDC 3
 SPC 3
 ISC 8
AIS = American Spinal Injury Association (ASIA) Impairment 
Scale, IDC = indwelling catheter, SPC = suprapubic catheter, 
ISC = intermittent self-catheterisation.
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People with spinal cord 
injury admitted to spinal 
injury units (n = 104)
Eligible (n = 14)
Measured urine output, swelling, spasticity and impact of spasticity
Randomised (n = 14)
(n = 7)                                                                                                        (n = 7)
Excluded (n = 90)
t NBKPSMPXFSMJNCQBUIPMPHZJOKVSZ	O

t non-compliant with rehabilitation (n = 7)
t MPXFSMJNCNPUPSQPXFS	O

t -./MFTJPOEJEOPUUPMFSBUF&4	O

t NFEJDBMMZVOmUDPHOJUJWFJNQBJSNFOU	O

t non-English-speaking background (n = 5)
t < 8 weeks before discharge (n = 5)
t declined to participate (n = 2)
Experimental intervention
t FES cycling
t usual rehabilitation
Control intervention
t usual rehabilitation
Measured urine output, swelling, spasticity and impact of spasticity
(n = 7)                                                                                                        (n = 7)
Washout period
Measured urine output, swelling, spasticity and impact of spasticity
(n = 7)                                                                                                        (n = 7)
Measured urine output, swelling, spasticity, impact of spasticity,
global impression of change and inconvenience
(n = 7)                                                                                                        (n = 7)
Control intervention
Day 14
Day 0
Day 22
Day 36
Experimental intervention
Figure 1. Design and ﬂow of participants through the trial. ES = electrical stimuation,  
FES = functional electrical stimulation, LMN = lower motor neuron.
Effect of intervention
The results for all outcomes are presented in Table 2, 
with individual participant data presented in Table 3 (see 
eAddenda for Table 3). The mean between-group difference 
for urine output was 82 mL (95% CI –35 to 199), where 
a positive value favours the experimental intervention 
because it indicates an increase in urine output with FES 
cycling. The other mean between-group differences were 
–0.1 cm (95% CI –1.5 to 1.2) for lower limb swelling, –1.9 
points (95% CI –4.9 to 1.2) on the 32-point Ashworth Scale, 
and –5 points (95% CI –13 to 2) on the 164-point PRISM. 
Here, negative values favour the experimental intervention 
because they indicate a decrease in swelling and spasticity 
with FES cycling.
All but two participants reported improvements with the 
FES cycling on the Global Impression of Change Scale with 
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a median improvement of 3 points (IQR 3 to 4) on the scale 
from –7 to +7. The median perception of inconvenience 
of the FES cycling was 0.3 points (IQR 0 to 3.8) on the 
10-point Visual Analogue Scale. There were two reports 
of adverse effects. One related to an increase in spasticity 
and the other related to precipitation of a bowel accident. 
All but two participants cited one or more of the following 
therapeutic effects: decreases in swelling or spasticity; 
improvements in circulation, urine output, bowel activity or 
‘muscle tone’; and increased feelings of general wellbeing 
including improvements in ability to breathe, a sense of 
making progress with physical activity and psychological 
beneﬁts from seeing their legs move.
Discussion
Despite widespread beliefs about the beneﬁts of FES 
cycling on urine output, lower limb swelling and spasticity, 
we were unable to detect a convincing treatment effect 
on any of these variables. However, our results cannot be 
interpreted as evidence of no treatment effect because this 
interpretation relies on deﬁning a minimally worthwhile 
treatment effect and it is not clear what size treatment 
effect clinicians and people with spinal cord injury would 
consider sufﬁcient to justify the time and cost associated 
with FES cycling. If people with spinal cord injury would 
consider a treatment effect equivalent to 10% of mean initial 
values then our results could be used to indicate that FES 
cycling has no effect on lower limb swelling. Regardless, 
our results provide valuable data for future meta-analyses 
which may be the only way of answering questions about 
the effectiveness of FES cycling on these parameters in 
people with spinal cord injury. Our results and protocol also 
provide useful information for future trials.
Our point estimates of treatment effects for some variables 
were imprecise as reﬂected in the wide 95% CI associated 
with the between-group differences. This was particularly 
a problem for urine output. To increase the precision of 
our point estimates we needed a larger sample size and/
or tighter inclusion criteria. We tried to minimise the need 
for a large sample size by using a cross-over design. Our 
research question was appropriate for a cross-over design 
because any effects of FES cycling on urine output are 
probably short lived. We could have tightened our inclusion 
criteria. For example, those with AIS A lesions may respond 
better and more consistently to FES cycling than those with 
AIS B, C or D lesions because they tolerate higher levels of 
stimulation. However, by restricting the inclusion criteria 
we would have also restricted the ability to generalise 
the results to a broad population. Setting the inclusion 
criterion of clinical trials is always a balance between these 
competing considerations.
There are no other studies investigating the effect of FES 
cycling on urine output against which to compare our 
results. At least one study provides indirect evidence to 
support the theory that FES cycling reduces swelling via its 
therapeutic effects on venous return. This study examined 
the effect of ES contractions on lower limb swelling during 
static standing on a tilt table in able-bodied individuals 
(Man et al 2003). The authors reported a notable between-
group difference in lower limb swelling measured via 
water volumetry, with a mean between-group difference of 
39 mL (95% CI 17 to 61 – estimated from provided data). 
There are obvious limitations of extrapolating the indirect 
evidence from this study. Nonetheless, along with studies 
demonstrating an effect of ES cycling on venous return 
(Elokda et al 2000, Faghri and Yount 2002, Sampson et al 
2000), the study by Man and colleagues indicates some basis 
for the rationale that FES cycling in people with spinal cord 
injury inﬂuences venous return and lower limb swelling; a 
5BCMF. Mean (SD) of measures before and after the experimental and control interventions, mean (SD) difference within 
interventions, and mean (95% CI) difference between interventions, except Global Impression of Change and perception of 
inconvenience, which are presented as median with interquartile range. Small numerical anomalies are due to the effects of 
rounding.
Outcomes Intervention Difference within interventions
Difference between 
interventions
Pre Post Post minus Pre Post minus pre
Exp Con Exp Con Exp Con Exp minus Con
(n = 14) (n = 14) (n = 14) (n = 14) (n = 14) (n = 14)
Urine output (mL) 97 (72)
123 
(91)
163 
(136)
106 
(68)
66  
(127)
–16 
(105)
82a 
(–35 to 199)
Leg circumference (cm)
49.2 
(4.3)
49.6 
(3.7)
49.3 
(4.6)
49.8 
(4.1)
0.1 
(2.0)
0.3 
(1.5)
–0.1b 
(–1.5 to 1.2)
Ashworth (0 to 32) 5.6 (4.6)
6.1 
(5.7)
2.8 
(2.3)
5.1 
(4.6)
–2.9 
(3.9)
–1.0 
(3.1)
–1.9b 
(–4.9 to 1.2)
PRISM (0 to 164) 24 (11)
23 
(10)
22 
(9)
26 
(20)
–2 
(4)
3 
(12)
–5b 
(–13 to 2)
Global Impression of 
Change (–7 to +7)
3 
(3 to 4)
Perception of 
inconvenience (0 to 10)
0.3 
(0 to 3.8)
Exp = experimental phase = Functional Electrical Stimulation (FES) cycling, Con = control phase = usual care, PRISM = Patient Reported 
Impact of Spasticity Measure. aA positive number favours FES cycling indicating an increase in urine output. bA negative number favours 
FES cycling indicating a decrease in swelling or spasticity.
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conclusion not supported by our leg circumference results. 
The results from the small number of studies examining the 
effects of FES cycling on spasticity are similar to ours with 
no clear indication of therapeutic effect (Krause et al 2008, 
Skold et al 2002, van der Salm et al 2006).
The potential effect of FES cycling on urine output may 
have been missed because we only measured urine output 
over a one-hour period immediately after FES cycling. 
One hour may be too short. However this seems unlikely 
because naturetic peptide has an immediate effect on 
the kidneys (Dunn and Donnelly 2007). If the release of 
naturetic peptide in response to an increase in venous return 
is the main mechanism by which FES cycling increases 
urine output, then our time frame for measurements of 
urine output should have been sufﬁcient. Another possible 
explanation for our failure to ﬁnd a convincing treatment 
effect is our use of a short intervention period, namely 
two weeks. A longer training period may have increased 
participants’ muscle bulk and stimulated strength (Baldi 
et al 1998) thereby enhancing the muscle pump effect 
and venous return. Venous return may have been further 
increased by the stimulation of additional lower limb 
muscles however stimulation of more than three muscle 
groups is problematic as this requires additional expensive 
equipment not routinely available in the clinical setting. 
Future studies could manipulate some of these variables to 
determine their effect on urine output.
Only the immediate effects of FES cycling were investigated 
and only at the impairment level. We acknowledge that urine 
output, lower limb swelling and spasticity are surrogate 
measures for what is important to people with spinal cord 
injury, and clearly immediate effects are of little interest 
unless they are sustained. We however restricted the trial 
in this way to increase statistical power. In addition, it is 
potentially wasteful of resources looking for sustained 
effects of interventions on global measures of participation 
without ﬁrst demonstrating immediate effects on surrogate 
measures.
Importantly, FES cycling is advocated in people with motor 
complete lesions for reasons other than its effect on urine 
output, lower limb swelling and spasticity. For example, it 
is advocated on the basis that it increases cardiovascular 
ﬁtness, muscle bulk and lean muscle mass. There is also 
some evidence to suggest that FES cycling prevents bone 
loss and contractures, and decreases adipose tissue and the 
risk of diabetes (Carlson et al 2009, Hicks et al 2011). We 
did not look at any of these variables because they were 
unlikely to be inﬂuenced by two weeks of FES cycling.
Interestingly, all but two participants when asked to rate 
change from the FES cycling on the Global Impression 
of Change Scale stated that it made them ‘somewhat’ 
to ‘moderately’ better, as reﬂected by a median score 
of 3 points (IQR 3 to 4). Some argue that even a 1-point 
change on the Global Impression of Change Scale should 
be considered clinically signiﬁcant by deﬁnition (Schneider 
and Olin 1996, p. 278). While we do not fully agree with 
this interpretation of clinical signiﬁcance, it does indicate 
that some may interpret our results as convincing evidence 
of treatment effectiveness. When asked open-ended 
questions about the beneﬁcial or detrimental effects of FES 
cycling, most participants stated only beneﬁcial effects 
including improvements in urine output and reductions in 
lower limb swelling and spasms. It is difﬁcult to explain 
the discrepancy between participants’ reports of treatment 
efﬁcacy and the results of the objective measures. The most 
likely explanation is that participants were not blinded and 
therefore had expectations about treatment effectiveness. 
These expectations may have been due to preconceived 
ideas regarding the therapeutic beneﬁts of FES cycling. 
However, the same effectiveness of FES cycling on 
spasticity was not reﬂected in the PRISM results; an 
assessment of spasticity that also relies on self-report. This 
may be because the PRISM is structured and participants 
are asked to focus speciﬁcally on the implications of their 
spasticity over the last week. This may minimise bias. Of 
course, the discrepancy between participants’ reports of 
treatment efﬁcacy and the results of the objective measures 
may reﬂect participants’ ability to sense changes that our 
measures were incapable of detecting.
In all, a cautious interpretation of our results is that two 
weeks of FES cycling does not have clear beneﬁcial effects 
on urine output, lower limb swelling, or spasticity in people 
with recent spinal cord injury, and that our conﬁdence in the 
therapeutic effects of FES cycling on these variables is not 
yet justiﬁed. It is therefore not clear whether FES cycling 
should be prescribed for these purposes. Q
Footnotes: aRT300 cycle, Restorative Therapies, USA.
eAddenda: Table 3 available at jop.physiotherapy.asn.au
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